NCT03011736View on ClinicalTrials.gov

Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 12, 2016

Primary Completion Date

July 12, 2018

Study Completion Date

December 24, 2018

Conditions
Parathyroid Gland AdenomaPrimary Hyperparathyroidism
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Parathyroidectomy

Undergo parathyroidectomy

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT03011736 - Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter